Propranolol Dosing for Portal Hypertension in Cirrhosis

Dosage and Administration

The American Association for the Study of Liver Diseases recommends a starting dose of propranolol of 40 mg twice daily, increasing to 80 mg twice daily as needed to achieve the therapeutic goal 1, 2, 3
The therapeutic objective is to reduce the hepatic venous pressure gradient (HVPG) to less than 12 mmHg or achieve a 20% reduction from baseline 5
The dose can be increased up to 80 mg twice daily as needed and tolerated 1, 2, 3
To improve compliance, long-acting propranolol can be used at a dose of 80 or 160 mg 1, 2

In patients with cirrhosis and ascites, the maximum recommended dose should be reduced to 160 mg daily, compared to 320 mg daily in those without ascites 6
In patients with refractory ascites, it may be safer to use low doses of propranolol (80 mg/day) 6

The American Association for the Study of Liver Diseases lists contraindications for propranolol use, including asthma, severe chronic obstructive pulmonary disease (COPD), heart block, significant bradycardia, hypotension, and decompensated heart failure 5, 6

Regular monitoring of heart rate is necessary to adjust the dose 5
In patients with end-stage liver disease, particularly those with refractory ascites or spontaneous bacterial peritonitis, close monitoring of blood pressure and renal function is essential 6
Propranolol therapy should be continued indefinitely, as discontinuation can increase the risk of variceal bleeding and mortality 5, 6

In cases of contraindications or intolerance to propranolol, endoscopic variceal ligation is the treatment of choice 1, 2, 3, 6
In difficult situations where neither propranolol nor endoscopic variceal ligation can be used, isosorbide mononitrate (20 mg twice daily) is the first-line treatment 1, 2, 3